Hypothesis

Serum indole-3-propionic acid (IPA) modulates the rate of biological aging by altering DNA methylation patterns through activation of the pregnane X receptor (PXR) in intestinal epithelial and immune cells.

Rationale

• Existing data show IPA is produced exclusively by gut Clostridium species from tryptophan [1,3] and correlates strongly with the bacterial gene fldC (r=0.80) [1].
• IPA activates PXR, driving anti‑inflammatory, gut‑barrier and insulin‑sensitizing effects [1,3]
• PXR signaling regulates expression of DNA methyltransferases (DNMT1, DNMT3A) and demethylases (TET2) in hepatocytes and macrophages, a link demonstrated in xenobiotic metabolism studies [6]
• Therefore, fluctuations in intestinal IPA concentration could shift the DNMT/TET balance, producing measurable changes in epigenetic clocks such as GrimAge or PhenoAge.

Novel Mechanistic Insight

We propose that IPA‑bound PXR recruits co‑repressors that suppress DNMT transcription while enhancing TET activity, leading to locus‑specific hypomethylation at promoters of pro‑inflammatory genes (e.g., IL6, TNF). This epigenetic reprogramming would reduce inflammaging‑associated methylation signatures, thereby lowering biological age estimates.

Testable Predictions

1. Cross‑sectional: In a diverse human cohort (n≥1000), serum IPA concentration will be negatively correlated with GrimAge acceleration (β≈‑0.15 per SD increase, p<0.01) after adjusting for age, sex, BMI, and kidney function [2].
2. Intervention: A 12‑week polyphenol‑rich diet or a defined Clostridium sporogenes probiotic that raises serum IPA by ≥30% will decrease GrimAge acceleration by ≥0.5 years relative to placebo (two‑sided t‑test, p<0.05) [5]
3. Mechanistic: Peripheral blood mononuclear cells from high‑IPA participants will show reduced DNMT1 mRNA and increased TET2 expression, with concomitant hypomethylation at CpG sites within the IL6 promoter (measured by targeted bisulfite sequencing) [6]
4. Falsifiability: If IPA supplementation fails to alter GrimAge acceleration or the DNMT/TET expression ratio, the hypothesis is refuted.

Required Methods

• Recruit participants across age strata (40‑80 y) with normal renal function.
• Quantify serum IPA via LC‑MS/MS.
• Calculate biological age using GrimAge algorithm from Illumina EPIC arrays.
• Measure gut fldC abundance by shotgun metagenomics.
• Perform PBMC RNA‑seq for DNMT/TET transcripts and targeted bisulfite sequencing for selected CpGs.
• Statistical analysis: linear mixed models, mediation analysis to test whether IPA effects on GrimAge are mediated by DNMT/TET expression.

Expected Impact

Confirming this link would position IPA as a modifiable, microbiome‑derived regulator of epigenetic aging, opening nutraceutical or probiotic strategies to delay age‑related decline.